Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Inhibition of the activity of poly(ADP-ribose) polymerase in haemorrhagic shock

M. McDonald, H. Mota-Filipe, M. Abdelrahman, M. Threadgill, C. Thiemermann

Med Sci Monit 2003; 9(1): 41- :: ID: 15104

Abstract

There is good evidence that haemorrhagic shock is associated with the generation of reactive oxygen species (ROS) including superoxide anions and hydrogen peroxide [1]. It has been suggested that the activation of PARP plays a role in the cardiovascular failure associated with haemorrhagic shock [2], but there is little information regarding the role of PARP in the pathophysiology of the organ dysfunction/injury associated with haemorrhagic shock. Here we investigate the effects of several PARP inhibitors on the circulatory failure and the organ injury and dysfunction caused by severe haemorrhage and resuscitation in the anaesthetised rat. Male Wistar rats were anaesthetised with thiopentone sodium (120 mg/kg i.p.) and instrumented for the measurement of mean arterial pressure and heart rate. Haemorrhage (to lower blood pressure to ~50 mmHg for 90 min) and resuscitation (with blood and an equivalent volume of Ringers Lactate solution), resulted within 4 h in a delayed fall in blood pressure as well as in renal dysfunction, liver injury and dysfunction, pancreatic injury, and neuromuscular injury. Treatment of rats subjected to haemorrhage and resuscitation with the PARP inhibitors 3-aminobenzamide (10 mg/kg), nicotinamide (10 mg/kg), or 1,5 dihydroxyisoquinoline (ISO, 3 mg/kg) attenuated the multiple organ injury and dysfunction caused by haemorrhage and resuscitation. However, treatment with the vehicle for ISO (10% v/v DMSO) had a similar effect. As the beneficial effects of ISO (the most potent and specific PARP inhibitor) were, in part, due to its vehicle, further studies with the potent, specific and water soluble inhibitor of PARP activity, 5-aminoisoquinolinone (5-AIQ), were performed to ensure that the reduction by the agents of the multiple organ failure in haemorrhagic shock is indeed due to their ability to inhibit PARP activity. Administration (5 min prior to resuscitation of 5-AIQ (0.03 mg/kg i.v, or 0.3 mg/kg i.v.) reduced (in a dose-related fashion) the multiple organ injury and dysfunction, but did not affect the circulatory failure, associated with haemorrhagic shock. In conclusion, this study demonstrates that chemically distinct inhibitors of PARP activity attenuate the renal dysfunction, the hepatocellular injury and the pancreatic injury associated with severe haemorrhage and resuscitation. References: 1.Redl H, Gasser H, Schlag G, Marzi I: Involvement of oxygen radicals in shock related cell injury. Br Med Bull, 1993; 49: 556-65 2.Szabo C: Potential role of peroxynitrite-poly (ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock, 1998; 9: 341-344

Keywords: PARP, haemorrhage, multiple organ injury, Shock

0 Comments

Editorial

01 March 2023 : Editorial  

Editorial: Global Surveillance of Highly Pathogenic Avian Influenza Viruses in Poultry, Wild Birds, and Mammals to Prevent a Human Influenza Pandemic

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.939968

Med Sci Monit 2023; 29:e939968

SARS-CoV-2/COVID-19

29 March 2023 : Editorial  

Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...

Med Sci Monit In Press; DOI: 10.12659/MSM.940519  

30 March 2023 : Clinical Research  

An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...

Med Sci Monit In Press; DOI: 10.12659/MSM.939485  

09 February 2023 : Clinical Research  

Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...

Med Sci Monit 2023; 29:e938892

In Press

30 Mar 2023 : Clinical Research  

An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...

Med Sci Monit In Press; DOI: 10.12659/MSM.939485  

30 Mar 2023 : Database Analysis  

Global Research Trends and Hotspots in Lateral Epicondylitis During the Past 30 Years: A Bibliometric and V...

Med Sci Monit In Press; DOI: 10.12659/MSM.939309  

29 Mar 2023 : Editorial  

Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...

Med Sci Monit In Press; DOI: 10.12659/MSM.940519  

29 Mar 2023 : Laboratory Research  

Preparation, Physicochemical Properties, and Structural Characterization of Resistant Starch-Aspirin-Loaded...

Med Sci Monit In Press; DOI: 10.12659/MSM.939711  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750